Chris Coons US Inactive
CHRIS COONS FOR DELAWARE
Ad copy
On the 47th anniversary of the Roe v. Wade decision, I’m proud to have the endorsement of Planned Parenthood Action. Make no mistake, Republicans in Washington and in states across the country want to turn back the clock on women’s access to health care — I’ll do everything I can to ensure that doesn’t happen, which is why I signed a brief last month urging the Supreme Court to defend Roe v. Wade and respect legal precedent. I will continue to stand with Planned Parenthood Action Fund and work to protect reproductive rights. https://www.plannedparenthoodaction.org/2020-endorsements
↗ View in Meta Ad Library (the live creative — image/video/layout)
Performance proxies
| Overall score | 42.4/100 |
| Spend / Reach / Long. / Eff. | 30.5 · 70.7 · 3.9 · 64.4 |
| Spend range | USD 800–899 |
| Impressions | 50,000 – 59,999 |
| CPM (≈ $/1k impr) | USD 15.45 |
| Est. audience size | — |
| Days live | 15 (2020-01-23 → 2020-02-07) |
| Created | 2020-01-23 |
| Creative variants | 1 body · 0 headline |
| Platforms | |
| Languages | en |
| Candidate | DE — Chris Coons |
| Surfaced by | “senate:Chris Coons” |
🧠 AI analysis
| Issue | abortion |
| Framing | positive candidate |
| Message type | persuasion |
| Emotional appeal | pride |
| Production tier | semi pro |
| Who pictured | candidate |
| Symbols | healthcare, family |
| Call to action | none |
| Standout element | Bold magenta Planned Parenthood endorsement graphic overlaid on candidate photo creates instant organizational credibility |
| Tactic | Leverages a high-profile progressive endorsement on a symbolic anniversary to reinforce Coons as the definitive defender of reproductive rights against Republican opposition. |
Where it ran (delivery by region)
| Delaware | 16.1% |
| California | 7.3% |
| Florida | 6.1% |
| Pennsylvania | 5.1% |
| New York | 4.7% |
| Texas | 4.6% |
| Michigan | 3.8% |
Who saw it (delivery)
| 45-54 · unknown | 0.0% |
| 35-44 · male | 1.3% |
| 65+ · unknown | 0.4% |
| 18-24 · female | 0.3% |
| 25-34 · male | 1.0% |
| 25-34 · female | 0.9% |
| 55-64 · unknown | 0.2% |
| 18-24 · male | 0.4% |
| 45-54 · male | 2.9% |
| 25-34 · unknown | 0.0% |
| 35-44 · female | 1.2% |
| 45-54 · female | 3.4% |
| 55-64 · female | 14.7% |
| 65+ · male | 19.3% |
| 55-64 · male | 8.5% |
| 65+ · female | 45.5% |
| 35-44 · unknown | 0.0% |
